Interleukin-10 responses to therapeutic vaccination during highly active antiretroviral therapy and after analytical therapy interruption.

Interleukin-10 responses to therapeutic vaccination during highly active antiretroviral therapy and after analytical therapy interruption.

We investigated whether therapeutic vaccination in highly active antiretroviral therapy (HAART)-treated patients with a modified vaccinia virus Ankara-vectored HIV-1 vaccine, with or without therapy interruption, induced the production of interleukin (IL)-10. Plasma IL-10 levels were not significant...

Deskribapen osoa

Xehetasun bibliografikoak
Egile Nagusiak:	Yang, H, Guimarães-Walker, A, Hibbs, S, Dong, T, Stacey, A, Borrow, P, Hanke, T, Davenport, M, McMichael, A, Dorrell, L
Formatua:	Journal article
Hizkuntza:	English
Argitaratua:	2009

Antzeko izenburuak

Highly active antiretroviral therapy interruption: predictors and virological and immunologic consequences.
nork: Touloumi, G, et al.
Argitaratua: (2006)

Therapeutic immunization of highly active antiretroviral therapy-treated HIV-1-infected patients: safety and immunogenicity of an HIV-1 gag/poly-epitope DNA vaccine.
nork: Dorrell, L, et al.
Argitaratua: (2005)

TILT: a randomized controlled trial of interruption of antiretroviral therapy with or without interleukin-2 in HIV-1 infected individuals.
nork: Angus, B, et al.
Argitaratua: (2008)

Antiretroviral therapy interruptions: impact on HIV treatment and transmission
nork: Dubrocq G, et al.
Argitaratua: (2018-06-01)

Broad TCR usage in functional HIV-1-specific CD8+ T cell expansions driven by vaccination during highly active antiretroviral therapy.
nork: Yang, H, et al.
Argitaratua: (2007)

Effect of analytical treatment interruption and reinitiation of antiretroviral therapy on HIV reservoirs and immunologic parameters in infected individuals.
nork: Katherine E Clarridge, et al.
Argitaratua: (2018-01-01)

Interruption of antiretroviral therapy is associated with increased plasma cystatin C.
nork: Mocroft, A, et al.
Argitaratua: (2009)

Heightened resistance to host type 1 interferons characterizes HIV-1 at transmission and after antiretroviral therapy interruption
nork: Gondim, MVP, et al.
Argitaratua: (2021)

Interleukin-10 contributes to reservoir establishment and persistence in SIV-infected macaques treated with antiretroviral therapy
nork: Justin Harper, et al.
Argitaratua: (2022-04-01)

Virological remission after antiretroviral therapy interruption in female African HIV seroconverters
nork: Gossez, M, et al.
Argitaratua: (2018)

Unwillingness of patients in Ghana to interrupt antiretroviral therapy for HIV cure research
nork: Evelyn Y. Bonney, et al.
Argitaratua: (2021-03-01)

Antiretroviral Therapy Interruption (ATI) in HIV-1 Infected Patients Participating in Therapeutic Vaccine Trials: Surrogate Markers of Virological Response
nork: Lorna Leal, et al.
Argitaratua: (2020-08-01)

Safety and tolerability of recombinant modified vaccinia virus Ankara expressing an HIV-1 gag/multiepitope immunogen (MVA.HIVA) in HIV-1-infected persons receiving combination antiretroviral therapy.
nork: Dorrell, L, et al.
Argitaratua: (2007)

Therapeutic vaccination following early antiretroviral therapy elicits highly functional T cell responses against conserved HIV-1 regions
nork: Jakub Kopycinski, et al.
Argitaratua: (2023-10-01)

Hypophosphataemia with non-tenofovir-containing antiretroviral therapy.
nork: Wainwright, E, et al.
Argitaratua: (2013)

Immune control of HIV-1 infection after therapy interruption: immediate versus deferred antiretroviral therapy
nork: Bernaschi Massimo, et al.
Argitaratua: (2009-10-01)

13 HIV-1-specific ADCC following anti-latency therapy and analytical treatment interruption
nork: W.S. Lee, et al.
Argitaratua: (2017-07-01)

Predictors of SIV recrudescence following antiretroviral treatment interruption
nork: Mykola Pinkevych, et al.
Argitaratua: (2019-10-01)

Thymic Output and CD4 T-Cell Reconstitution in HIV-Infected Children on Early and Interrupted Antiretroviral Treatment: Evidence from the Children with HIV Early Antiretroviral Therapy Trial
nork: Lewis, J, et al.
Argitaratua: (2017)

Immunologic changes during unplanned treatment interruptions of highly active antiretroviral therapy in children with human immunodeficiency virus type 1 infection.
nork: Gibb, D, et al.
Argitaratua: (2004)

Real-time predictions of reservoir size and rebound time during antiretroviral therapy interruption trials for HIV
nork: A.L. Hill, et al.
Argitaratua: (2015-12-01)

Biological determinants of immune reconstitution in HIV-infected patients receiving antiretroviral therapy: The role of interleukin 7 and interleukin 7 receptor alpha and microbial translocatioa
nork: Rajasuriar, R., et al.
Argitaratua: (2010)

Interrupting antiretroviral therapy in HIV cure trials during COVID-19: Adaptation to low transmission settings
nork: Jillian SY. Lau, et al.
Argitaratua: (2021-03-01)

Longitudinal bioluminescent imaging of HIV-1 infection during antiretroviral therapy and treatment interruption in humanized mice.
nork: John D Ventura, et al.
Argitaratua: (2019-12-01)

Expression of type I interferon-associated genes at antiretroviral therapy interruption predicts HIV virological rebound
nork: P. Zacharopoulou, et al.
Argitaratua: (2022-01-01)

Analytical Treatment Interruption after Short-Term Antiretroviral Therapy in a Postnatally Simian-Human Immunodeficiency Virus-Infected Infant Rhesus Macaque Model
nork: Ria Goswami, et al.
Argitaratua: (2019-10-01)

Interruptions of antiretroviral therapy in children and adolescents with HIV infection in clinical practice: a retrospective cohort study in the USA
nork: Natella Rakhmanina, et al.
Argitaratua: (2016-01-01)

Differences in Expression of Selected Interleukins in HIV-Infected Subjects Undergoing Antiretroviral Therapy
nork: Beata Szymańska, et al.
Argitaratua: (2022-05-01)

Time to HIV viral rebound and frequency of post-treatment control after analytical interruption of antiretroviral therapy: an individual data-based meta-analysis of 24 prospective studies
nork: Gunst, JD, et al.
Argitaratua: (2025)

Interruption of antiretroviral therapy to augment immune control of chronic HIV-1 infection: risk without reward.
nork: Abbas, U, et al.
Argitaratua: (2002)

HIV Drug Resistance Mutations Detection by Next-Generation Sequencing during Antiretroviral Therapy Interruption in China
nork: Miaomiao Li, et al.
Argitaratua: (2021-02-01)

Factors Affecting Virological Outcome When First-Line Antiretroviral Therapy Is Reintroduced After Unplanned Interruption
nork: Suzy Maria MD, et al.
Argitaratua: (2020-01-01)

Real-Time Predictions of Reservoir Size and Rebound Time during Antiretroviral Therapy Interruption Trials for HIV.
nork: Alison L Hill, et al.
Argitaratua: (2016-04-01)

Long-term outcome of patients after a single interruption of antiretroviral therapy: a cohort study
nork: Machado Carmen, et al.
Argitaratua: (2012-10-01)

A case report of clinical implications of a delayed antiretroviral therapy switch in a patient with multiple treatment interruptions
nork: Mireille A Mpalang Kakubu, et al.
Argitaratua: (2022-12-01)

Clinical experience with plasmid DNA- and modified vaccinia virus Ankara-vectored human immunodeficiency virus type 1 clade A vaccine focusing on T-cell induction.
nork: Hanke, T, et al.
Argitaratua: (2007)

Randomized trial of time-limited interruptions of protease inhibitor-based antiretroviral therapy (ART) vs. continuous therapy for HIV-1 infection.
nork: Cynthia Firnhaber, et al.
Argitaratua: (2011-01-01)

Monitoring of highly active antiretroviral therapy in HIV infection.
nork: Walker, A, et al.
Argitaratua: (2011)

Genetically-barcoded SIV facilitates enumeration of rebound variants and estimation of reactivation rates in nonhuman primates following interruption of suppressive antiretroviral therapy.
nork: Christine M Fennessey, et al.
Argitaratua: (2017-05-01)

Predicting short-term interruptions of antiretroviral therapy from summary adherence data: Development and test of a probability model.
nork: Rebecca Arden Harris, et al.
Argitaratua: (2018-01-01)